Results 1 to 10 of about 60,277 (349)

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach

open access: yesAntibiotics, 2021
Beta-lactam antibiotics are often the backbone of treatment for Gram-negative infections in the critically ill. Beta-lactams exhibit time-dependent killing, and their efficacy depends on the percentage of dosing interval that the concentration remains ...
Mohammad Al-Shaer, Charles A Peloquin
exaly   +3 more sources

Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis [PDF]

open access: yesAntibiotics, 2023
Beta-lactams are the main antibiotics for the treatment of invasive meningococcal disease. However, reduced susceptibility to penicillin G is increasingly reported in Neisseria meningitidis and reduced susceptibility to third-generation cephalosporines ...
Ala-Eddine Deghmane   +2 more
doaj   +2 more sources

Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review [PDF]

open access: yesFrontiers in Antibiotics
Orthotopic liver transplant (OLT) represents the standard of care for managing patients affected by end-stage and life-threatening liver diseases.
Milo Gatti   +3 more
doaj   +2 more sources

Extended Infusion of Beta-Lactams and Glycopeptides: A New Era in Pediatric Care? A Systematic Review and Meta-Analysis [PDF]

open access: yesAntibiotics
Optimizing antibiotic therapy is imperative with rising bacterial resistance and high infection mortality. Extended infusion defined as a continuous infusion (COI) or prolonged infusion (PI) of beta-lactams and glycopeptides might improve efficacy and ...
Andrea Rahel Burch   +3 more
doaj   +2 more sources

PBP4: A New Perspective on Staphylococcus aureus β-Lactam Resistance [PDF]

open access: yesMicroorganisms, 2018
β-lactam antibiotics are excellent drugs for treatment of staphylococcal infections, due to their superior efficacy and safety compared to other drugs.
Thaina M. da Costa   +3 more
doaj   +4 more sources

Rise of the beta-lactams: a retrospective, comparative cohort of oral beta-lactam antibiotics as step-down therapy for hospitalized adults with acute pyelonephritis [PDF]

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Objective: The aim of this study was to determine if oral beta-lactam therapy is non-inferior to alternative therapy at discharge following inpatient treatment with an IV cephalosporin for acute pyelonephritis.
Athena L.V. Hobbs   +5 more
doaj   +2 more sources

The current view on betalactam resistance in Staphylococcus aureus [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2021
The review presents the current view on the different resistance mechanisms of Staphylococcus aureus to beta-lactams, which are ones of the main antibiotics of choice for the treatment of staphylococcal infections. Currently, there are several mechanisms
Gostev V.V.   +2 more
doaj   +1 more source

Hypotheses for synthesis of novel chiral beta-amino-beta-lactams through amidines

open access: yesResults in Chemistry, 2021
Synthesis of new beta-lactams is an attractive field because some of these types of molecules are biologically active. The design and preparation of C4-nitrogen-substituted beta-lactams are not known.
Bimal Krishna Banik, Alberto Boretti
doaj   +1 more source

Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry

open access: yesWorld Allergy Organization Journal, 2023
Background: Although beta-lactams are 1 of the major causative agents of severe cutaneous adverse reactions (SCAR), their epidemiology and clinical aspects have been poorly studied.
Min-Hye Kim, MD, PhD   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy